BioSpace News Archive

Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the “Company”), a western Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products announces that its strategic partners Symeres are licensed to produce large quantities of controlled compounds required by Nirvana.

Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, views new data on skin cancer prevalence provided by the American Cancer Society1, indicating approximately 3.4 million U.S. residents could be diagnosed with non-melanoma skin cancer (NMSC) in 2022, as strongly supportive of the commercial opportunity for the Company’s flagship product Ameluz®.

According to Emergen Research, the global wearable healthcare devices market size was USD 7.37 billion in 2019 and is expected to reach USD 34.89 billion in 2027 and register a robust CAGR of 21.5% during the forecast period, 2020-2027.

Increasing prevalence of chronic diseases, rapid adoption of electronic health records and eHealth solutions, and rising number of product launches are expected to drive global market growth

Increasing number of surgeries, rising awareness about benefits of ultrasound guided regional anesthesia over traditional methods, and high prevalence of orthopedic disorders, diabetes, cardiovascular diseases across the globe are some key factors expected to fuel market growth

According to Emergen Research, the global eHealth Care market size was USD 61.99 billion in 2019 and is expected to reach USD 314.55 billion in 2027 and register a revenue CAGR of 22.4% during the forecast period, 2020-2027.

The government and non-government investments in cancer research & development, coupled with the large scale end uses of stem cell research are influencing the market growth.

Rising volume of complex data and reduction in hardware costs is projected to drive growth of the artificial intelligence in healthcare market.

Rise in awareness of gastrointestinal disorders, muscle improvement and fat reduction supplements are the major factors influencing market growth.

High demand for electronic skin in the healthcare sector to treat diabetes and cardiology diseases is driving market growth.